• Accueil >
  • Publications >
  • Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets

Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets

1 nov. 2019European Journal of Cancer

DOI : 10.1016/j.ejca.2019.09.001

Auteurs

A. Moreira, J. Masliah-Planchon, C. Callens, S. Vacher, C. Lecerf, M. Frelaut, E. Borcoman, N. Torossian, F. Ricci, S. Hescot, M.P. Sablin, P. Tresca, D. Loirat, S. Melaabi, O. Trabelsi-Grati, G. Pierron, D. Gentien, V. Bernard, A. Vincent Salomon, N. Servant, I. Bieche, C. Le Tourneau, M. Kamal